Sanders calls on FDA to allow low-cost rivals to $375k Catalyst drugUS Senator Bernie Sanders says the FDA should allow pharmacies and generic manufacturers to make low-cost copies of Share XSanders calls on FDA to allow low-cost rivals to $375k Catalyst drughttps://pharmaphorum.com/news/sanders-calls-on-fda-to-allow-low-cost-rivals-to-375k-catalyst-drug/
Price cut unlocks NICE nod for Perjeta in post-surgery breast cancerRoche has finally won NICE backing for the use of Perjeta (pertuzumab) to prevent early-stage HER2-positive breast cancer Share XPrice cut unlocks NICE nod for Perjeta in post-surgery breast cancerhttps://pharmaphorum.com/news/price-cut-unlocks-nice-nod-for-perjeta-in-post-surgery-breast-cancer/
Doctors and patient groups struggle with CAR-T ‘hype’Managing patients’ expectations of CAR-T therapies is proving to be a huge challenge from when selection decisions are Share XDoctors and patient groups struggle with CAR-T ‘hype’https://pharmaphorum.com/news/doctors-and-patient-groups-struggle-with-car-t-hype/
Novartis makes quality of life case for Cosentyx with new dataThere is increasing recognition that skin clearance scores may not be enough to win over patients and doctors Share XNovartis makes quality of life case for Cosentyx with new datahttps://pharmaphorum.com/news/novartis-makes-quality-of-life-case-for-cosentyx-with-new-data/
Alkermes/Biogen hope for less tummy trouble with new MS pillAlkermes and Biogen have filed a new multiple sclerosis pill with the FDA, which they hope will treat Share XAlkermes/Biogen hope for less tummy trouble with new MS pillhttps://pharmaphorum.com/news/alkermes-biogen-hope-for-less-tummy-trouble-with-new-ms-pill/
Brexit affecting supplies of generic drugs, say pharmacistsBrexit is already affecting supply and prices of drugs in UK pharmacies, the BBC has reported. The BBC’s Share XBrexit affecting supplies of generic drugs, say pharmacistshttps://pharmaphorum.com/news/brexit-affecting-supplies-of-generic-drugs-say-pharmacists/
Medical devices ‘linked to deaths and injuries’ claim investigatorsMedical devices firm Medtronic has been linked to thousands of deaths and injuries, according to a report published Share XMedical devices ‘linked to deaths and injuries’ claim investigatorshttps://pharmaphorum.com/news/medical-devices-linked-to-deaths-and-injuries-claim-investigators/
Gene therapy firm BioMarin stages haemophilia musicalBioMarin Pharmaceutical has put on a stage musical to raise awareness about haemophilia, and determine whether creative expression Share XGene therapy firm BioMarin stages haemophilia musicalhttps://pharmaphorum.com/news/gene-therapy-firm-biomarin-stages-haemophilia-musical/
FDA panel backs Sage’s novel antidepressant but turns down Alkermes’Sage’s Zulresso (brexanolone) is on course for approval for postnatal depression in the US after a positive vote Share XFDA panel backs Sage’s novel antidepressant but turns down Alkermes’https://pharmaphorum.com/news/fda-panel-backs-sages-novel-antidepressant-but-turns-down-alkermes/
Amazon sells exclusive diabetes and hypertension devicesAmazon has launched an exclusive range of medical devices to help people manage their diabetes and hypertension at Share XAmazon sells exclusive diabetes and hypertension deviceshttps://pharmaphorum.com/news/amazon-sells-exclusive-diabetes-and-hypertension-devices/
Janssen and Arrowhead strike $3.7bn RNAi dealJanssen has struck a deal with Arrowhead Pharmaceuticals to develop an RNA interference drug to treat hepatitis B Share XJanssen and Arrowhead strike $3.7bn RNAi dealhttps://pharmaphorum.com/news/janssen-and-arrowhead-strike-3-7bn-rnai-deal/
MS campaigner Trishna Bharadia scoops Woman of the Year awardMultiple sclerosis campaigner Trishna Bharadia has been named Woman of the Year at the 2018 Asian Achievers Awards Share XMS campaigner Trishna Bharadia scoops Woman of the Year awardhttps://pharmaphorum.com/news/ms-campaigner-trishna-bharadia-scoops-woman-of-the-year-award/
Lack of blood cancer awareness in China and Japan – Janssen reportJanssen has published a report revealing significant gaps in understanding of blood cancer in individuals in China and Share XLack of blood cancer awareness in China and Japan – Janssen reporthttps://pharmaphorum.com/news/blood-cancer-awareness-china-japan-janssen/
Can pharma halt the world’s obesity crisis?Lancet research reveals scale of problem Share XCan pharma halt the world’s obesity crisis?https://pharmaphorum.com/views-and-analysis/can-pharma-halt-the-worlds-obesity-crisis/
NICE backs funding for Kyowa Kirin’s bone disorder drugChildren in England and Wales with a rare inherited disorder causing soft and weak bones can have access Share XNICE backs funding for Kyowa Kirin’s bone disorder drughttps://pharmaphorum.com/news/nice-backs-funding-for-kyowa-kirins-bone-disorder-drug/
FDA warns of genital gangrene risk with diabetes drug classThe US regulator released an official risk warning of a rare genital infection identified in 12 patients, including Share XFDA warns of genital gangrene risk with diabetes drug classhttps://pharmaphorum.com/news/risk-sglt2-inhibitors-fda-warns/
England reveals plans allowing abortion pill to be taken at homeWomen in England will be able to take an early abortion pill in the safety of their own Share XEngland reveals plans allowing abortion pill to be taken at homehttps://pharmaphorum.com/news/england-reveals-plans-allowing-abortion-pill-to-be-taken-at-home/
Ada health app launches in Spanish and PortugueseThe most uninsured ethnic group in the US can now access health information via new Spanish and Portuguese Share XAda health app launches in Spanish and Portuguesehttps://pharmaphorum.com/news/ada-health-app-launches-spanish/
